Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- levamisole
- Protopic (tacrolimus topical)
Interactions between your drugs
levamisole tacrolimus topical
Applies to: levamisole, Protopic (tacrolimus topical)
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Coadministration of topical tacrolimus with other immunosuppressive agents may potentiate the immunosuppressive effects of topical tacrolimus. However, data concerning its safety and efficacy in combination with immunosuppressants are not available. According to the prescribing information, rare cases of skin malignancy and lymphoma have been reported in patients who have received treatment with topical calcineurin inhibitors, including topical tacrolimus. On the other hand, systemic exposure from topical tacrolimus is reported to be less than 1 ng/mL. In addition, the lowest tacrolimus blood concentration from topical application at which systemic effects can be observed is unknown.
MANAGEMENT: According to the manufacturer, use of topical tacrolimus in immunocompromised patients is not recommended. Therefore, until further information is available, it may be advisable to avoid its concomitant use with other immunosuppressants. Screening for the development of malignancy during and after treatment may also be considered.
Drug and food interactions
levamisole food
Applies to: levamisole
Ask your doctor before using levamisole together with ethanol (alcohol). You should avoid drinking alcohol, it can increase some of the side effects of levamisole. This can cause nausea, dizziness, vomiting, and upset stomach. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Topotecan
Topotecan is used for cancer, cervical cancer, ovarian cancer, small cell lung cancer
Chlorambucil
Chlorambucil (Leukeran) is an anti-cancer chemotherapy drug used for treatment of Hodgkin’s disease ...
Vinblastine
Vinblastine is used for breast cancer, cancer, choriocarcinoma, histiocytosis, hodgkin's lymphoma ...
Ifosfamide
Ifosfamide is used for cancer, cervical cancer, testicular cancer
Fludarabine
Fludarabine is used for cancer, chronic lymphocytic leukemia, chronic myelogenous leukemia ...
Etoposide
Etoposide is used for cancer, hodgkin's lymphoma, multiple myeloma, ovarian cancer, small cell lung ...
Vincristine
Vincristine is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.